Web Results

law.justia.com/cases/federal/appellate-courts/ca2/15-0690/15-0690-2017-11-21.html

Nov 21, 2017 ... The Second Circuit held that the settlement agreements released plaintiffs' non- turnover claims with respect to some but not all of the banks; the assets at issue were in fact located abroad, but that those assets may nonetheless be subject to turnover under state law pursuant to an exercise of the court's in ...

www.gpo.gov/fdsys/pkg/USCOURTS-dcd-1_01-cv-02094

01-2094 - PETERSON, et al v. ISLAMIC REPUBLIC, et al.

www.supremecourt.gov/opinions/15pdf/14-770_9o6b.pdf

Apr 20, 2016 ... See United States v. Detroit Timber & Lumber Co., 200 U. S. 321, 337. SUPREME COURT OF THE UNITED STATES. Syllabus. BANK MARKAZI, AKA CENTRAL BANK OF IRAN v. PETERSON ET AL. CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR. THE SECOND CIRCUIT. No. 14–770 ...

digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=2240&context=fac_pubs

Sep 13, 2012 ... STATUTORY INTERPRETATION: BRUESEWITZ V WYETH. Donald G. Gifford ..... the majority's decision to bar all design defect claims against vaccine manufacturers is one that. Congress should ...... 951 (1993). 247. See DEWEES ET AL.. supra note 238, at 393 ("It was thought that by relegating the courts.

www.druganddevicelawblog.com/2014/07/innovator-liability-at-100.html

Jul 18, 2014 ... Wyeth, Inc., 850 N.W.2d 353 (Iowa 2014), but Huck isn't even the last case on our scorecard any longer – that honor currently belongs to Johnson v. ..... Kansas has as product liability statute, K.S.A. §60-3301, et seq., which merges all common- law theories and requires that the defendant be in the chain of ...

www.cdlinjurylaw.com/our-successes

Jun 6, 2016 ... Gaskin, et al. v. Wyeth. Six plaintiffs suffered valvular heart disease after taking the diet drug Fen Phen. The case settled for a confidential amount after eight ... Lockhart v. Peterson Manufacturing, et al. – $1,650,000 settlement from one defendant and a confidential settlement from a second defendant for a ...

scocal.stanford.edu/opinion/th-v-novartis-pharmaceuticals-corporation-34554

Dec 21, 2017 ... T.H., a Minor, etc., et al., Plaintiffs and Appellants, S233898 v. Ct.App. 4/1 D067839 NOVARTIS PHARMACEUTICALS CORPORATION, San Diego County .... It is the brand-name manufacturer that bears responsibility for the accuracy and adequacy of its label “as long as the drug is on the market.” (Wyeth v.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1867573

Before the expression profiling portion of the study, the cellular compositions of the purified PBMC pellets from patients in all three groups (healthy patients, ..... cells, and/or monocytes (M.E. Burczynski et al, unpublished observation), which suggests that transcripts previously associated with platelets can originate from the ...

www.iadclaw.org/assets/1/7/Rafferty_v._Merck__Co._-_Brief_for_Amicus_Curiae_IADC_(Oct._10_2017).pdf

Oct 10, 2017 ... Huck v. Wyeth,. 850 N.W.2d 353 (Iowa 2014) ....................passim. In re Zofran ( Ondansetron) Products. Liability Litigation,. No. 15-md-2657, __ F. Supp. .... Ramos v. Brenntag. Specialties, Inc., et al., No. 8218176 (Cal.); Tincher v. Omega Flex, Inc., No. 17 MAP 2013 (Pa.); and T.H.,. A Minor, ETC., et al., v.